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An indirect immunofluorescence test was used during 1982-1983 to identify antibodies to
Lyme disease spirochetes in humans, white-footed mice, and raccoons. Serologic tests detected
IgM or total Ig antibodies in serum samples from 67 persons. Onset of illness, as marked by
erythema chronicum migrans (ECM), occurred mainly during July and August. The majority
ofthe persons with Lyme disease lived in south central and southeastern Connecticut. Analyses
also verified prior spirochetal infections in 29 of323 (9 percent) white-footed mice and in three
of 34 (9 percent) raccoons captured at sites with or without evidence of human infections.
Results indicate potential for Lyme disease at numerous localities in Connecticut.
Lyme disease is endemic at several locations in south central and southeastern
Connecticut. Based on clinical records, human infections may have originated in at
least 33 communities [1]. The suspected tick vector, Ixodes dammini, is present at
many of these sites [2] and may transmit spirochetes, the etiologic agent of this
disease [3,4], to humans and other animals [4,5-9].
It is often difficult to determine accurately sources of human infection from case
histories. The characteristic skin lesion, erythema chronicum migrans (ECM), may
appear within three weeks after a tick bite [1,10], and, consequently, persons may
not recall tick bites. When ticks are found, many people are unable to determine
precisely the time or place of exposure. Therefore, in addition to clinical records,
supportive data are needed to assess the risk for Lyme disease in various com-
munities. Serologic analyses of wildlife provide important information on the
distribution ofzoonotic diseases. The purpose ofthis study was to expand on earlier
investigations [1,8,9] by indicating residences of persons who recently had Lyme
disease and by identifying areas where white-footed mice (Peromyscus leucopus)
and raccoons (Procyon lotor) have had spirochete infections.
MATERIALS AND METHODS
Sera of persons thought to have Lyme disease were typically drawn 7-21 days
after onset ofECM or arthritis. Specimens were forwarded along with case histories
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the Connecticut State Health Department. Additional clinical data were obtained
from the attending physicians if sera reacted positively in serologic tests. In addition
to age, sex, and place of residence, the following information was recorded: history
of tick bites, date of onset of illness, presence of ECM, and development of other
manifestations such as arthritic, cardiac, and neurologic disorders. Because travel
histories were unknown, residences of patients were separated into two categories-
probable areas for Lyme disease (defined by multiple cases or by evidence of
spirochetes in ticks or mammals) and possible sites for infection (single cases in areas
not previously reported).
White-footed mice and raccoons were captured as described earlier [11] from late
spring to late fall during 1976-1982. Following anesthetization, blood was drawn
from the heart, and sera were stored at -60°C. Mammals were returned to their
respective habitats.
Human sera were obtained during July 1982-October 1983 and were screened for
antibodies to Lyme disease spirochetes by indirect immunofluorescent antibody
(IFA) tests. Sources of reagents and procedures for isolation and maintenance of
spirochetes, antigen preparations, and for analyses of human and wildlife sera have
been reported [5,8,12]. In initial tests, we used a polyvalent conjugate, fluorescein
isothiocyanate-labeled goat anti-human total immunoglobulins (Ig), to detect an-
tibodies in patients. Subsequently, all serum samples were retested with fluorescein-
tagged goat anti-human IgM immunoglobulins. Conjugated rabbit antisera to rac-
coon and white-footed mouse globulins (Ig) were produced in hyperimmunized
animals at the Centers for Disease Control in Atlanta, Georgia. Confirmation of
Lyme disease in humans was based on a history of ECM with one or more of the
following criteria: a fourfold rise in IgM or total Ig titers or single titers 2 1:64.
Without documentation of ECM, serologic reactions at or above these dilutions
were considered presumptive evidence of Lyme disease. Titers of > 1:64 and
2 1:32 were significant for raccoons and white-footed mice, respectively. All tests
included antigen and positive and negative serum controls.
RESULTS
We compiled records for 67 persons who had significant levels of lgM or total Ig
antibodies to spirochetes. Clinical histories for 18 males (5-58 years) and 16 females
(2-73 years) with ECM (Table 1) indicated that onset of illness, as marked by ex-
panding skin lesions, was most prevalent during July and August (n = 27); 13 peo-
ple recalled tick bites. Headaches, fever, fatigue, myalgias, or malaise accompanied
ECM. Arthralgias and/or arthritis developed weeks or months after ECM in 18 in-
dividuals. Four of these also had neurologic complications (two each with facial
palsy and meningitis). Serologic analyses revealed elevated Ig antibody titers
(1:128-1:8,192) in samples from all 34 persons and identified IgM antibodies
(1:128-1:2,048) in 14 of these. Seroconversions (negative to positive) were recorded
for two of seven paired serum samples.
The residences of 34 persons who had ECM are located mainly in south central
and southeastern Connecticut (Fig. 1). Ofthe 25 communities identified, the follow-
ing probably had multiple cases: Old Lyme(three), East Haddam (three), Colchester
(three), Middletown (two), Lyme (two), and Portland (two). Single cases were
reported from coastal areas (Old Saybrook, New London, Madison, Stonington,
and Darien) and inland sites (Amston, East Lyme, New Britain, Moodus, Un-
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TABLE I
Seasonal Occurrence of Human Cases of Lyme Disease Based on the Presence of
ECM and Serologic Evidence, July 1982-October 1983
Number with
Time of No. of % of History of Cardiac Neurologic
ECM Appearance Cases Total Tick Bite Arthralgias Arthritis Disordersa Disordersb
1982
July-Aug. 12 35 6 10 5 3
Sept.-Oct. 3 9 2 1
Nov.-Dec. 0
1983
Jan.-April 0
May-June 4 12 2 2 2
July-Aug. 15 44 5 4 1 1
Sept.-Oct. 0
Total 34 13 18 8 1 4
aMyocarditis noted without accompanying arthritic or neurologic disorders
bMeningitis (two), facial palsy (two)
casville, Chester, Stafford Springs, Lisbon, Hartford, Higganum, South Norwalk,
Bristol, Glastonbury, and Salem).
Clinical data were available for an additional 19 males (4-61 years) and 14 females
(7-71 years) who may have also had Lyme disease. Although ECM was not noted,
serologic tests detected Ig antibodies to spirochetes in sera collected throughout the
year (Table 2). Similar to the previous group, the number of cases reported was
relatively high (n = 15) during July and August. The majority (n = 24) sought
medical attention after developing arthralgias, and of these, eight reported tick
bites. Serologic tests also identified IgM antibodies in sera from 13 patients (n = 8
during June-August). Like those who had ECM, these individuals all had total Ig
and IgM antibodies at titers of 1:128-1:16,384 and 1:128-1:2,048, respectively.
Analyses of paired samples revealed seroconversions for four of 12 persons. .~~~~~~~~~~~~~~
f ~~~ ~ ~~~~(2) (2)0
5 (3) (2) *
0
FIG. 1. Distribution of Humans with ECM and Antibodies residences of persons who
\*< had ECM and antibodies to
spirochetes, 1982-1983.
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Seasonal Occurrence of Presumptive Human Cases of Lyme Disease Based on Serologic Evidelnce,
July 1982-October 1983
Number with
Time of No. of % of History of Neurologic
Medical Examination Cases Total Tick Bite Arthralgias Arthritis Disordersa
1982
July-Aug. 4 12 1 2 1
Sept.-Oct. 1 3 1
Nov.-Dec. 5 15 5 5 2
1983
Jan.-April 4 12 1 4 3
May-June 4 12 1 2 1
July-Aug. I1 33 3 8 3
Sept.-Oct. 4 12 2 2 2 1
Total 33 8 24 14 4
"Encephalitis (one), facial palsy (three)
Residences ofthe 33 persons with antibodies to spirochetes but without records of
ECM are distributed principally throughout south central and southeastern Con-
necticut (Fig. 2). There was evidence of Lyme disease for individuals living in
Amston (n = 5), Norwich (four), Marlborough (two), Hadlyme (two), and Essex
(two). Additional cases were noted for Moodus, Lyme, Portland, Old Lyme,
Groton, Colchester, East Lyme, East Haddam, Glastonbury, Salem, Manchester,
Haddam, Waterford, Noank, Killingworth, North Franklin, Newington, and
Lebanon.
Immunofluorescence tests verified prior spirochetal infections in 29 of 323 white-
footed mice (Table 3) and in three of 34 raccoons (Table 4). Positive raccoons were
captured during July and August at three sites where no human cases have been
reported. Similarly, serologic tests revealed antibodies in white-footed mice from
three additional locations, two of which had evidence of spirochete infections in
humans. These areas were scattered throughout southern Connecticut (Fig. 3).
(2) 05)
*(4)
FIG. 2. Distribution of
/ </ ~~~~~~~~~~~~~~residences of persons who
Humans with Antibodies (No ECM) hadantes toso- / ~~~~~~~~~~~~~~~~had antibodies to spiro-
chetes but had no history of
ECM, 1982- 1983.
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TABLE 3
Sera of White-Footed Mice Analysed for Antibodies to Spirochetes in Connecticut
No. of Samples at
Number No. (%) Reciprocal TitrationEndpoinits
Sites Tested Positive 32-64 128-256 512-1,024
Branford 52 2 (4) 1 1
Colchester 13 0
Danielson 6 0
East Lyme 75 7 (9) 2 5
New Fairfield 10 0
Stonington 124 20 (16) 1 19
Thompson 12 0
Woodbridge 23 0
Voluntown 8 0
Total 323 29 (9) 3 25 1
TABLE 4
Sera of Raccoons Analyzed for Antibodies to Spirochetes in Conllecticut
No. of Samples at
Reciprocal Titration
Number Number Endpoints
Sites Tested Positive 64-128 256-512
Cheshire 3 0
East Haven 3 1 1
Guilford 14 0
Hamden 4 0
Hebron 4 0
North Branford 1 1 I
North Haven 1 0
West Hartford 2 0
Woodbridge 2 1 1
Total 34 3 1 2
FIG. 3. Distribution of
raccoons and white-footed
mice with antibodies to
spirochetes, 1976-1982.
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Human cases of Lyme disease were clustered chiefly in south central and
southeastern Connecticut. If these people were bitten by infected ticks near their
homes, spirochetes may have been acquired in 38 communities, 17 of which have
been previously reported[1]. Recent records for some sites such as Darien, Amston,
Middletown, Portland, and South Norwalk probably reflect a greater awareness of
Lyme disease among physicians and health officials. Although it appears from this
study that Lyme disease may also be spreading in the state, we recognize that some
people may have traveled to endemic areas and were bitten by infected ticks
elsewhere. Even though the precise places of origins for these human infections are
unknown, our results agree with those of Steere and Malawista [1] and show poten-
tial for this disease at several locations.
Lyme disease occurs in both coastal and inland areas where the vector, L dam-
mini, is found and where deer populations are increasing [2]. Microscopic examina-
tions ofmidgut tissues from immature or adult L dammini have revealed spirochetes
at East Haddam, Haddam, East Lyme, Lyme, Guilford, and Voluntown [4,5,9].
Therefore, there are numerous foci where persons may encounter infected ticks.
Documentation of Lyme disease or ECM in different states and continents [1,4],
where L dammini or related ticks occur, indicates a distribution over broad
geographic regions. If L dammini populations increase, this tick may disperse and
extend the range of this disease.
Based on the timing of ECM, an important clinical marker for Lyme disease
[1,13], persons were infected primarily during the summer. This confirms earlier
studies [14,151 and suggests a relationship between the prevalence of new human
cases and relatively high populations ofL dammininymphs [2,16]. Although 21 per-
sons reported tick bites in the present study, specimens were not available for iden-
tification. Therefore, it is unclear whether these people had encounteredI. dammini
or Dermacentor variabilis, another common tick found throughout the state [2].
Nonetheless, with increased exposure to ticks during warmer months, there is
greater potential for Lyme disease.
UnlikeD. variabilis,I. dammini larvae and nymphs will feed on humans [17]. The
juvenile stages of the latter species may harbor spirochetes [4,5], and because these
ticks are small, they are likely to be overlooked even after they engorge blood. This
may account, in part, for the relatively low number of persons with histories of tick
bites and reinforces the importance of checking for ticks after visiting infested
habitats.
Comparisons of our two case populations indicate similar distributions of where
spirochete infections for Lyme disease may have been acquired. These results also
show the usefulness ofserologic tests even when knowledge of ECM is lacking. The
detection ofIgM or total Ig antibodies, combined with clinical and geographic infor-
mation, may provide important clues as to the cause of certain arthritic, cardiac, or
neurologic disorders. As indicated earlier [4], significant rises inlgM and IgG titers
can be demonstrated if blood samples are drawn at appropriate times in the course
of illness. In addition to time of sampling, the relatively low number of seroconver-
sions noted in our study might be due to differences in immune responses or, as
noted by Steere et al. [4], to the effects of antibiotics.
We detected antibodies to spirochetes in white-footed mice and raccoons from six
widely separated coastal and inland sites. This adds to previous work [8] which iden-
tified antibodies in both mammals at East Haddam and Lyme and, collectively, pro-
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vides supportive evidence for Lyme disease in areas where humans may have been
infected. Of the 329 white-footed mouse and 78 raccoon sera collected from these
sites during 1978-1982, 10 percent and 23 percent, respectively, contained antibodies
[8]. Similar studies of white-tailed deer at these and other locations in south central
and southeastern Connecticut [9] revealed positivity rates of29-39 percent. Because
spirochetes have also been isolated from the blood of these hosts [5,71, we believe
that these mammals may serve as reservoirs for this agent.
Since several hosts are commonly parasitized by L dammini [2,7-9,16], sampling
wildlife populations may prove useful in the identification and monitoring of
endemic areas. The present and earlier findings [5,8,9] show a close correlation
among the distributions of infected ticks, mammals with antibodies to spirochetes,
and residences of persons who had Lyme disease. However, some communities,
such as Colchester and Guilford, appear to have had human cases [1], but there is no
evidence of spirochete infections in raccoons or white-footed mice. This could be
due to insufficient sampling. Thus, surveillance programs should include tests for
spirochetes in ticks and serologic analyses of mammalian sera from scattered sites
within towns. Studies should also be conducted over several months to determine if
there are temporal differences in vector-pathogen-host interrelationships.
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